<VariationArchive RecordType="classified" VariationID="10867" VariationName="FANCB, 3314-BP DEL" VariationType="Deletion" Accession="VCV000010867" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-12-11" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="25906" VariationID="10867">
      <GeneList>
        <Gene Symbol="FANCB" FullName="FA complementation group B" GeneID="2187" HGNC_ID="HGNC:3583" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>Xp22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="14689524" stop="14873069" display_start="14689524" display_stop="14873069" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="14861528" stop="14891183" display_start="14861528" display_stop="14891183" Strand="-" />
          </Location>
          <OMIM>300515</OMIM>
          <Haploinsufficiency last_evaluated="2021-06-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FANCB">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-06-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FANCB">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>FANCB, 3314-BP DEL</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp22.31</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>3314-BP DEL</Name>
      </OtherNameList>
      <XRefList>
        <XRef ID="FANCB_000061" DB="LOVD 3" />
        <XRef Type="Allelic variant" ID="300515.0002" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff could not provide an HGVS expression for allelic variant 300515.0002.  Although it is described as 10693del3314, suggesting the breakpoints are known, the numbering system was not specified.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="FANCB, 3314-BP DEL AND Fanconi anemia complementation group B" Accession="RCV000011614" Version="4">
        <ClassifiedConditionList TraitSetID="3035">
          <ClassifiedCondition DB="MedGen" ID="C1845292">Fanconi anemia complementation group B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2004-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2004-11-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15502827</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3035" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1275" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Fanconi anemia complementation group B</ElementValue>
                <XRef ID="MONDO:0010351" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">FANCONI PANCYTOPENIA, TYPE 2</ElementValue>
                <XRef Type="MIM" ID="300514" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FA2</ElementValue>
                <XRef Type="MIM" ID="300514" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">FANCB</ElementValue>
                <XRef Type="MIM" ID="300514" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FACB</ElementValue>
                <XRef Type="MIM" ID="300514" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">FANCB-Related Fanconi Anemia</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Fanconi anemia (FA) is characterized by physical abnormalities, bone marrow failure, and increased risk for malignancy. Physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and/or lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies. Progressive bone marrow failure with pancytopenia typically presents in the first decade, often initially with thrombocytopenia or leukopenia. The incidence of acute myeloid leukemia is 13% by age 50 years. Solid tumors – particularly of the head and neck, skin, and genitourinary tract – are more common in individuals with FA.</Attribute>
                <XRef ID="NBK1401" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301575</ID>
                <ID Source="BookShelf">NBK1401</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301753</ID>
                <ID Source="BookShelf">NBK5192</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="FARF, 2008">
                <URL>http://www.fanconi.org/images/uploads/other/Guidelines_for_Diagnosis_and_Management.pdf</URL>
                <CitationText>Fanconi Anemia Research Fund, Guidelines for Diagnosis and Management, 2008 (See 2020 Update)</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="FARF, 2020">
                <URL>https://www.fanconi.org/images/uploads/other/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.pdf</URL>
                <CitationText>Fanconi Anemia Clinical Care Guidelines, Fifth Edition.</CitationText>
              </Citation>
              <XRef ID="84" DB="Orphanet" />
              <XRef ID="C1845292" DB="MedGen" />
              <XRef ID="MONDO:0010351" DB="MONDO" />
              <XRef Type="MIM" ID="300514" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="31846" SubmissionDate="2012-09-07" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300515.0002_FANCONI ANEMIA, COMPLEMENTATION GROUP B" title="FANCB, 3314-BP DEL_FANCONI ANEMIA, COMPLEMENTATION GROUP B" />
        <ClinVarAccession Accession="SCV000031846" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2004-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an individual with Fanconi anemia of complementation group B (300514), Meetei et al. (2004) found a 3,314-bp deletion of the FANCB gene that included the promoter region and exon 1 (10693del3314). The mother and sister of the proband were carriers.</Attribute>
              <Citation>
                <ID Source="PubMed">15502827</ID>
              </Citation>
              <XRef DB="OMIM" ID="300514" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FANCB" />
          </GeneList>
          <Name>FANCB, 3314-BP DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3314-BP DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300515.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">FANCONI ANEMIA, COMPLEMENTATION GROUP B</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="31846" TraitType="Disease" MappingType="Name" MappingValue="FANCONI ANEMIA, COMPLEMENTATION GROUP B" MappingRef="Preferred">
        <MedGen CUI="C1845292" Name="Fanconi anemia complementation group B" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

